Remedent Inc 's ability to collect accounts receivable sequentially worsen to 2.93, indicating more challenging environment then in the second quarter 2021, but still, it is a far cry from any concerns. Remedent Inc 's Accounts Receivable average collection period in the Dec 31 2020 quarter, has increased to 125 days, from 124 days, in the Sep 30 2020 quarter.

If we take a look into Healthcare sector 433 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 3213, from overall ranking in the second quarter 2021 at 3411.

What is Receivable Turnover Ratio?
What is Remedent Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

REMI Receivables Turnover Ratio	(Dec 31 2020) III. Quarter	(Sep 30 2020) II. Quarter	(Jun 30 2020) I. Quarter	(Mar 31 2020) IV. Quarter	(Dec 31 2019) III. Quarter
Y / Y Receivable Change	30.55 %	-9.55 %	-16.4 %	40.8 %	-22.69 %
Y / Y Revenue Change	28.77 %	32.99 %	-29.31 %	-38.03 %	-37.5 %
Receivable Turnover Ratio (TTM)	2.93	2.95	2.64	2.77	3.38
REMI's Total Ranking	# 3213	# 3411	# 3208	# 2877	# 3534
Accounts Receivable average collection period days	125	124	138	132	108
Seq. Receivable Change	18.39 %	19.22 %	2.1 %	-9.41 %	-17.97 %
Seq. Revenue Change	4.83 %	46.91 %	-12.46 %	-4.49 %	8.26 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 142
Healthcare Sector	# 434
Overall Market	# 3213

Receivable Turnover Ratio Statistics
High	Average	Low
0.6	0.38	0.13
(June 30. 2015)		(Jun 30 2020)

REMI Company Profile • Back to REMI Efficiency Comparisons • Compare REMI Receivables Turnover Ratio to its Competitors

Financial Statements
Remedent Inc 's Accounts Receivable	$ 0 Millions	Visit REMI's Balance sheet
Remedent Inc 's Sales TTM	$ 1 Millions	Visit REMI's Income Statement
Sources of REMI's Revenues		Visit REMI's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
REMI's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
REMI's Growth Rates	REMI's Roa	REMI's Inventory Turnover Ratio	REMI's Dividend Comparisons
REMI's Profitability Ratios	REMI's Roi	REMI's Asset Turnover Ratio	REMI's Dividend Growth
REMI's Valuation Ratios	REMI's Roe	REMI's Financial Strength Ratios	REMI's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Dec 31 2020	Receivable at quarter ending Dec 31 2020
Ptc Therapeutics inc	6.54	$ 380.766 Millions	$ 58.246 Millions
Koninklijke Philips Nv	6.53	$ 21,879.200 Millions	$ 3,352.160 Millions
Envista Holdings Corporation	6.53	$ 2,282.000 Millions	$ 349.675 Millions
Bio rad Laboratories Inc	6.48	$ 2,545.626 Millions	$ 392.977 Millions
Ufp Technologies Inc	6.46	$ 179.373 Millions	$ 27.772 Millions
Boston Scientific Corporation	6.43	$ 9,913.000 Millions	$ 1,540.750 Millions
Stereotaxis Inc	6.42	$ 26.630 Millions	$ 4.145 Millions
Guardant Health Inc	6.42	$ 286.730 Millions	$ 44.647 Millions
Serina Therapeutics Inc	6.40	$ 1.868 Millions	$ 0.292 Millions
Teleflex Incorporated	6.33	$ 2,537.156 Millions	$ 400.537 Millions
Milestone Scientific Inc	6.32	$ 5.437 Millions	$ 0.860 Millions
Integra Lifesciences Holdings Corp	6.32	$ 1,371.868 Millions	$ 217.101 Millions
Merit Medical Systems Inc	6.31	$ 963.875 Millions	$ 152.869 Millions
Sutro Biopharma Inc	6.28	$ 42.722 Millions	$ 6.806 Millions
Carlisle Companies Incorporated	6.26	$ 4,245.200 Millions	$ 678.200 Millions
Enovis Corp	6.25	$ 3,070.769 Millions	$ 491.109 Millions
Quidelortho Corp	6.25	$ 1,661.668 Millions	$ 266.004 Millions
Prophase Labs Inc	6.24	$ 14.514 Millions	$ 2.324 Millions
Healthcare Services Group Inc	6.22	$ 1,760.303 Millions	$ 282.893 Millions
Gilead Sciences Inc	6.21	$ 24,689.000 Millions	$ 3,976.500 Millions
Amphastar Pharmaceuticals Inc	6.19	$ 349.846 Millions	$ 56.508 Millions
Pediatrix Medical Group Inc	6.18	$ 2,232.386 Millions	$ 361.351 Millions
Abbott Laboratories	6.15	$ 34,608.000 Millions	$ 5,623.750 Millions
Notable Labs Ltd	6.15	$ 0.922 Millions	$ 0.150 Millions
Novocure Limited	6.13	$ 494.366 Millions	$ 80.606 Millions
Avantor Inc	6.13	$ 6,393.600 Millions	$ 1,043.750 Millions
Siga Technologies Inc	6.09	$ 124.959 Millions	$ 20.509 Millions
Arbutus Biopharma Corp	6.06	$ 6.914 Millions	$ 1.142 Millions
Pliant Therapeutics Inc	6.05	$ 41.817 Millions	$ 6.911 Millions
Akebia Therapeutics Inc	6.05	$ 295.307 Millions	$ 48.826 Millions

Date modified: 2023-03-24T02:29:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.